WSO December 2023 – Issue 3 - 1159

Singhal
1159
40. Soo Y, Singhal AB, Leung T, et al. Reversible cerebral vasoconstriction
syndrome with posterior leucoencephalopathy
after oral contraceptive pills. Cephalalgia 2010; 30: 42-45.
41. Singhal AB, Kimberly WT, Schaefer PW and Hedley-Whyte
ET. Case records of the Massachusetts General Hospital. Case
8-2009. A 36-year-old woman with headache, hypertension,
and seizure 2 weeks post partum. N Engl J Med 2009; 360:
1126-1137.
42. Chen SP, Chung YT, Liu TY, Wang YF, Fuh JL and Wang SJ.
Oxidative stress and increased formation of vasoconstricting
F2-isoprostanes in patients with reversible cerebral vasoconstriction
syndrome. Free Radic Biol Med 2013; 61: 243-248.
43. Chen SP, Fuh JL, Wang SJ, Tsai SJ, Hong CJ and Yang AC.
Brain-derived neurotrophic factor gene Val66Met polymorphism
modulates reversible cerebral vasoconstriction syndromes.
PLoS ONE 2011; 6: e18024.
44. Chen SP, Wang YF, Huang PH, Chi CW, Fuh JL and Wang SJ.
Reduced circulating endothelial progenitor cells in reversible
cerebral vasoconstriction syndrome. J Headache Pain 2014;
15: 82.
45. Chen SP, Yang AC, Fuh JL and Wang SJ. Autonomic dysfunction
in reversible cerebral vasoconstriction syndromes.
J Headache Pain 2013; 14: 94.
46. Hsu WH, Wang SJ, Chao YM, et al. Urine metabolomics
signatures in reversible cerebral vasoconstriction syndrome.
Cephalalgia 2020; 40: 735-747.
47. Topcuoglu MA, Kursun O and Singhal AB. Coexisting vascular
lesions in reversible cerebral vasoconstriction syndrome.
Cephalalgia 2017; 37: 29-35.
48. Topcuoglu MA, Chan ST, Silva GS, Smith EE, Kwong KK
and Singhal AB. Cerebral vasomotor reactivity in reversible
cerebral vasoconstriction syndrome. Cephalalgia 2017; 37:
541-547.
49. Boitet R, Gaillard N, Bendiab E, et al. Concomitant reversible
cerebral vasoconstriction syndrome and transient global
amnesia. J Neurol 2020; 267: 390-394.
50. Ducros A, Fiedler U, Porcher R, Boukobza M, Stapf C and
Bousser MG. Hemorrhagic manifestations of reversible cerebral
vasoconstriction syndrome: frequency, features, and risk
factors. Stroke 2010; 41: 2505-2511.
51. Lange KS, Forster O, Mawet J, et al. Type of headache at
onset and risk for complications in reversible cerebral vasoconstriction
syndrome. Eur J Neurol 2022; 29: 130-137.
52. Lund AM and Al-Karagholi MA. COVID-19 vaccination
might induce reversible cerebral vasoconstriction syndrome
attacks: a case report. Vaccines 2022; 10: 823.
53. Ray S, Kamath VV, Raju PA, Kn R and Shalini N. Fulminant
reversible cerebral vasoconstriction syndrome in breakthrough
COVID 19 infection. J Stroke Cerebrovasc Dis 2022;
31: 106238.
54. Arandela K, Samudrala S, Abdalkader M, et al. Reversible
cerebral vasoconstriction syndrome in patients with coronavirus
disease: a multicenter case series. J Stroke Cerebrovasc
Dis 2021; 30: 106118.
55. Singhal AB, Caviness VS, Begleiter AF, Mark EJ, Rordorf G
and Koroshetz WJ. Cerebral vasoconstriction and stroke after
use of serotonergic drugs. Neurology 2002; 58: 130-133.
56. Nighoghossian N, Trouillas P, Loire R, Perrin L, Trillet V and
Gamondes P. Catecholamine syndrome, carcinoid lung tumor
and stroke. Eur Neurol 1994; 34: 288-289.
57. Yarnell PR and Caplan LR. Basilar artery narrowing and
hyperparathyroidism: illustrative case. Stroke 1986; 17:
1022-1024.
58. Iancu-Gontard D, Oppenheim C, Touzé E, et al. Evaluation
of hyperintense vessels on FLAIR MRI for the diagnosis
of multiple intracerebral arterial stenoses. Stroke 2003; 34:
1886-1891.
59. Chen SP, Fuh JL, Lirng JF and Wang SJ. Hyperintense vessels
on flair imaging in reversible cerebral vasoconstriction
syndrome. Cephalalgia 2012; 32: 271-278.
60. Kumar S, Goddeau RP Jr, Selim MH, et al. Atraumatic convexal
subarachnoid hemorrhage: clinical presentation, imaging
patterns, and etiologies. Neurology 2010; 74: 893-899.
61. Muehlschlegel S, Kursun O, Topcuoglu MA, Fok J and
Singhal AB. Differentiating reversible cerebral vasoconstriction
syndrome with subarachnoid hemorrhage from other
causes of subarachnoid hemorrhage. JAMA Neurol 2013; 70:
1254-1260.
62. Chen SP, Fuh JL, Chang FC, Lirng JF, Shia BC and Wang
SJ. Transcranial color Doppler study for reversible cerebral
vasoconstriction syndromes. Ann Neurol 2008; 63: 751-757.
63. Mijalski C, Dakay K, Miller-Patterson C, Saad A, Silver B
and Khan M. Magnesium for treatment of reversible cerebral
vasoconstriction syndrome: case series. Neurohospitalist
2016; 6: 111-113.
64. Muehlschlegel S, Rordorf G, Bodock M and Sims JR.
Dantrolene mediates vasorelaxation in cerebral vasoconstriction:
a case series. Neurocrit Care 2009; 10: 116-121.
65. Mukerji SS, Buchbinder BR and Singhal AB. Reversible cerebral
vasoconstriction syndrome with reversible renal artery
stenosis. Neurology 2015; 85: 201-202.
66. Mawet J, Boukobza M, Franc J, et al. Reversible cerebral
vasoconstriction syndrome and cervical artery dissection in
20 patients. Neurology 2013; 81: 821-824.
67. Wolff V and Ducros A. Reversible cerebral vasoconstriction
syndrome without typical thunderclap headache. Headache
2016; 56: 674-687.
68. Edlow JA. Managing patients with nontraumatic, severe,
rapid-onset headache. Ann Emerg Med 2018; 71: 400-408.
69. Cho S, Lee MJ, Gil YE and Chung CS. RCVS-TCH score
can predict reversible cerebral vasoconstriction syndrome in
patients with thunderclap headache. Sci Rep 2021; 11: 7750.
70. Schwedt TJ, Matharu MS and Dodick DW. Thunderclap headache.
Lancet Neurol 2006; 5: 621-631.
71. Chen SP, Fuh JL, Lirng JF, Chang FC and Wang SJ. Recurrent
primary thunderclap headache and benign CNS angiopathy:
spectra of the same disorder? Neurology 2006; 67:
2164-2169.
72. Camargo ECS and Singhal AB. Cerebral arteriopathies,
venous thrombosis, and migraine. Semin Neurol 2017; 37:
339-350.
73. Singhal AB. Diagnostic
challenges in RCVS, PACNS,
and other cerebral arteriopathies. Cephalalgia 2011; 31:
1067-1070.
74. Wong LK. Global burden of intracranial atherosclerosis. Int J
Stroke 2006; 1: 158-159.
75. Mandell DM, Matouk CC, Farb RI, et al. Vessel wall MRI
to differentiate between reversible cerebral vasoconstriction
syndrome and central nervous system vasculitis: preliminary
results. Stroke 2012; 43: 860-862.
International Journal of Stroke, 18(10)
WSO December 2023 – Issue 3

Table of Contents for the Digital Edition of WSO December 2023 – Issue 3
